Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.

      • Ghostalmedia@lemmy.world
        link
        fedilink
        English
        arrow-up
        8
        arrow-down
        1
        ·
        1 year ago

        True, but I think the shady thing is that the data transmission is framed as “Research Participation” - which sounds a lot better than “allow us to sell your data to other companies and institutions.”

        • Eager Eagle@lemmy.world
          link
          fedilink
          English
          arrow-up
          2
          arrow-down
          3
          ·
          1 year ago

          It’s understandable they phrase it like that when themselves are the main consumer of this data for their own research. I fail to see any shady behavior from their part here whatsoever. Regarding 23andMe, I’m vastly more concerned with the data leak episode they had recently and what they’re doing to prevent a future episode like this.

            • Eager Eagle@lemmy.world
              link
              fedilink
              English
              arrow-up
              1
              ·
              1 year ago

              ah that’s right, my bad. I remember not being sure if the credential reuse thing was 23andMe trying to downplay the attack, but it seems to really be the case. Not much to worry then.